{{medical}}
{{Drugbox
| verifiedrevid = 458472067
| IUPAC_name = E. coli L-asparagine amidohydrolase
| image = L-Asparaginase.png

<!--Clinical data-->
| tradename = Elspar
| Drugs.com = {{drugs.com|monograph|asparaginase}}
| MedlinePlus = a682046
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = POM
| legal_US = Rx-only
| legal_status =  
| routes_of_administration = 静脉注射，肌肉注射，皮下注射 

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism = 
| elimination_half-life = 8-30 hrs
| excretion =  

<!--Identifiers-->
| CASNo_Ref = {{cascite}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 9015-68-3
| ATC_prefix = L01
| ATC_suffix = XX02
| ATC_supplemental =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00023
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = G4FQ3CKY5R
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02997
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = NA

<!--Chemical data-->
| C=1377 | H=2208 | N=382 | O=442 | S=17 
| molecular_weight = 31731.9 g/mol
}}
'''门冬酰胺酶'''（{{lang-en|'''Asparaginase'''}}，{{EC number|3.5.1.1}}），又名'''天冬酰胺酶'''或'''天门冬酰胺酶'''，是一种催化[[天冬酰胺|天冬酰胺]][[水解|水解]]成[[天冬氨酸|天冬氨酸]]的[[酶|酶]]。在自然界中，一些[[微生物|微生物]]能产生这种酶。

==用途==
不同类型的门冬酰胺酶被用于不同的用途。

门冬酰胺酶常在[[食品工业|食品工业]]用作商品名为'''Acrylaway'''和'''PreventASe'''的[[食品|食品]]加工助剂。它能够减少[[淀粉|淀粉]]类食品（如[[饼干|饼干]]和[[薯片|薯片]]）中[[致癌物|致癌物]][[丙烯酰胺|丙烯酰胺]]的含量。<ref name="kornbrust">Kornbrust, B.A., Stringer, M.A., Lange, N.K. and Hendriksen, H.V. (2010) Asparaginase – an enzyme for acrylamide reduction in food products. In: Enzymes in Food Technology, 2nd Edition. (eds Robert J. Whitehurst and Maarten Van Oort). Wiley-Blackwell, UK, pp. 59-87.</ref>

另一种商品名为'''Elspar'''的门冬酰胺酶则在临床上其他药物联合用于治疗[[急性淋巴细胞白血病|急性淋巴细胞白血病]]（ALL）及某些[[淋巴瘤|淋巴瘤]]与[[肥大细胞瘤|肥大细胞瘤]]等癌症。<ref name=BNF57 /><ref name="pku" /><ref name="pmid17554375">{{cite journal |author=Appel IM, van Kessel-Bakvis C, Stigter R, Pieters R |title=Influence of two different regimens of concomitant treatment with asparaginase and dexamethason] on hemostasis in childhood acute lymphoblastic leukemia |journal= Leukemia|volume= 21|issue= 11|pages= 2377–80|year=2007 |pmid=17554375 |doi=10.1038/sj.leu.2404793}}</ref> 不同于大部分其他[[化疗|化疗]]药物，门冬酰胺酶可通过[[静脉注射|静脉注射]]、[[肌肉注射|肌肉注射]]或{{link-en|皮下注射|Subcutaneous injection}}给药而无须担心对周围组织的刺激与损害。

==作用机理==
===作为食品加工助剂===
在[[烘烤|烘烤]]或[[煎|煎]][[炸|炸]]含淀粉食物的时候（尤其是高温情况下），这类食物中天然存在的[[氨基酸|氨基酸]]天冬酰胺会与淀粉发生[[美拉德反应|美拉德反应]]，而该反应使得淀粉类食物变脆且呈现出独特的色泽、气味。然而，反应同时还会产生致癌物丙烯酰胺。

[[File:Maillard_reaction_asparagin.png|thumb]]

通过在烘烤或煎炸食物之前加入门冬酰胺酶，天冬酰胺被水解成为[[天冬氨酸|天冬氨酸]]和[[氨|氨]]。这使得天冬酰胺无法继续参与美拉德反应，从而显著减少食品加工时产生的丙烯酰胺量。门冬酰胺酶能够最多将各种淀粉类食品中的丙烯酰胺含量减少90%，同时不影响产品的味道与外观。<ref>{{Cite journal  | last1 = Hendriksen  | first1 = H.V.  | last2 = Kornbrust  | first2 = B.A.  | last3 = Oestergaard  | first3 = P.R.  | last4 = Stringer  | first4 = M.A.  | authorlink =   | coauthors =   | title = Evaluating the Potential for Enzymatic Acrylamide Mitigation in a Range of Food Products Using an Asparaginase from Aspergillus oryzae  | journal = Journal of Agricultural and Food Chemistry  | volume = 57  | issue = 10  | pages = 4168–4176  | publisher =   | location =   | date = 2009-04-23  | url = http://pubs.acs.org/doi/abs/10.1021/jf900174q  | issn =   | doi = 10.1021/jf900174q  | id =   | accessdate =  | pmid = 19388639}}</ref> 不过由于其他无天冬酰胺参与的反应也能产生少量的丙烯酰胺，目前生产上仍未能够做到完全杜绝这种致癌物的产生。<ref name="kornbrust"/>

===作为药物===
人体的普通[[细胞|细胞]]均可合成天冬酰胺，但某些[[癌细胞|癌细胞]]，尤其是急性淋巴细胞白血病细胞由于基因突变而无法合成这种非必需氨基酸。这使得它们需要大量的天冬酰胺，并强烈依赖于宿主的供给；门冬酰胺酶能够将<small>L</small>-天冬酰胺分解成天冬氨酸和氨，从而耗尽[[细胞外液|细胞外液]]中的这种氨基酸，抑制[[肿瘤|肿瘤]]细胞的[[蛋白质合成|蛋白质合成]]、[[细胞分裂|细胞分裂]]与细胞生长，最终导致[[细胞程序性死亡|细胞程序性死亡]]。其他细胞则不受影响。<ref>{{Cite journal | last1 = Broome | first1 = J. D. | title = L-Asparaginase: Discovery and development as a tumor-inhibitory agent | journal = Cancer treatment reports | volume = 65 Suppl 4 | pages = 111–114 | year = 1981 | pmid = 7049374}}</ref>

==药物副作用==
门冬酰胺酶的主要[[不良反应|不良反应]]是[[过敏|过敏]]或超敏反应，表现为[[发热|发热]]、[[寒战|寒战]]、血压下降、[[皮疹|皮疹]]，甚至有可能出现[[全身过敏反应|全身过敏反应]]以致[[休克|休克]]。<ref name=BNF57/> 除此之外，它还能够抑制某些[[蛋白质|蛋白质]]的合成，如[[凝血因子|凝血因子]]（一般为[[纤维蛋白原|纤维蛋白原]]）和抗凝血因子（一般为{{link-en|抗凝血酶|Antithrombin}}，有时还包括{{link-en|蛋白质C|Protein C}}和{{link-en|蛋白质S|Protein S}}），从而引起[[出血|出血]]或[[中风|中风]]。<ref name="js">{{Cite journal | last1 = Müller | first1 = H. 
| title = Use of L-asparaginase in childhood ALL | doi = 10.1016/S1040-8428(98)00015-8 | journal = Critical Reviews in Oncology/Hematology | volume = 28 
| issue = 2 | pages = 97–11 | year = 1998 | pmid =  | pmc = }}</ref> [[骨髓抑制|骨髓抑制]]亦十分常见，但通常较轻，极少达到需要为此而改变治疗方案的程度。<ref>{{Cite journal | last1 = Johnston | first1 = P. G. | last2 = Hardisty | first2 = R. M. | last3 = Kay | first3 = H. E. | last4 = Smith | first4 = P. G. | title = Myelosuppressive effect of colaspase (L-asparaginase) in initial treatment of acute lymphoblastic leukaemia | journal = British medical journal | volume = 3 | issue = 5923 | pages = 81–83 | year = 1974 | pmid = 4604804 | pmc = 1611087}}</ref>

其他常见副作用包括[[恶心|恶心]]、[[呕吐|呕吐]]、[[腹泻|腹泻]]、[[头痛|头痛]]、[[蛋白尿|蛋白尿]]、肝功能受损（黄疸）和[[胰腺炎|胰腺炎]]等。<ref name="pku">{{cite book | title=抗肿瘤药物手册 | publisher=北京大学医学出版社 | author=孙燕 | year=2006 | location=北京 | isbn=978-7-811-16205-9}}</ref>

==药物发现历史==
门冬酰胺酶的抗癌效应最早是在1953年被发现的——科学家观察到[[大鼠|大鼠]]和[[小鼠|小鼠]]的淋巴瘤在用[[豚鼠|豚鼠]]的[[血清|血清]]治疗后发生了退化。<ref>{{Cite journal 
| last1 = Kidd | first1 = J. G. | title = Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum | journal = The Journal of experimental medicine | volume = 98 | issue = 6 | pages = 565–582 | year = 1953 | pmid = 13109110 | pmc = 2136344 }}</ref> 之后研究者发现使肿瘤退化的不是血清本身，而是其中的门冬酰胺酶。<ref>{{Cite journal 
| last1 = Broome | first1 = J. D. | title = Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance | journal = The Journal of experimental medicine | volume = 118 | issue = 1 | pages = 99–120 | year = 1963 | pmid = 14015821 | pmc = 2137570 }}</ref> 随后在1966年和1967年对其进行了一系列的[[临床试验|临床试验]]，并逐渐将其投入治疗急性淋巴细胞白血病。<ref name="js" />

在比较不同类型的门冬酰胺酶后，人们发现由[[大肠杆菌|大肠杆菌]]（''Escherichia coli''）和{{link-en|菊欧文氏菌|Erwinia chrysanthemi}}（''Erwinia chrysanthemi''）产生的酶具有最好的抗癌能力。大肠杆菌产生的酶（即'''Elspar'''）因为除了效果好还容易做到大量生产，所以成为了目前门冬酰胺酶的主要来源。<ref name="js" /> 菊欧文氏菌产生的酶则采用另一个商品名'''Crisantaspase'''，或是在[[英国|英国]]销售时的商品名'''Erwinase'''。<ref name=BNF57>{{cite book |title=British National Formulary (BNF 57) |publisher=BMJ Group and RPS Publishing |location=United Kingdom |isbn=978-0-85369-845-6 |page=476 |chapter=8.1.5: Other antineoplastic drugs |author8=British Medical Association, Royal Pharmaceutical Society of Great Britain|date=March 2009}}</ref>

==参考资料==
{{reflist|2}}

==外部链接（英文）==
* {{MeshName|Asparaginase}}
* Macmillan Cancer Support上面的药物信息：[http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Treatmenttypes/Chemotherapy/Individualdrugs/Crisantaspase.aspx Crisantaspase information]
* [http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Asparaginase  美国国家卫生研究院的药物信息]

{{化疗药物}}
{{碳-氮非肽水解酶}}
{{氨基酸代谢酶类}}

{{Authority control}}
[[Category:作用于非肽碳-氮键的水解酶|Category:作用于非肽碳-氮键的水解酶]]
[[Category:抗肿瘤药|Category:抗肿瘤药]]